Dark
Light
System
Institutional Investment Manager
Cormorant Asset Management, LP
Cormorant Asset Management, LP (CIK: 0001583977) incorporated in Delaware, located at 200 Clarendon Street, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2015Q4)
Portfolio Summary: 82 holdings with a total value of $835,862,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ALKERMES PLC SHS 700,000 55,566,000 6.65%
2 DYAX CORP COM CVR 1,400,000 52,668,000 6.30%
3 HERON THERAPEUTICS INC 1,685,719 45,009,000 5.38%
4 EAGLE PHARMACEUTICALS INC COM 400,000 35,468,000 4.24%
5 NEUROCRINE BIOSCIE COM USD0.001 603,900 34,163,000 4.09%
6 OMEROS CORP 1,960,000 30,831,000 3.69%
7 ARDELYX INC COM 1,481,075 26,837,000 3.21%
8 PORTOLA PHARMACEUTICALS INC 500,000 25,725,000 3.08%
9 ALDER BIOPHARMACEUTICALS INC 757,475 25,019,000 2.99%
10 QUOTIENT LTD 1,519,100 24,306,000 2.91%
11 ALNYLAM PHARMACEUTICALS INC 245,000 23,064,000 2.76%
12 SAGE THERAPEUTICS 315,000 18,365,000 2.20%
13 SORRENTO THERAPEUTICS INC COM NEW 2,095,334 18,250,000 2.18%
14 NEVRO CORP 265,386 17,916,000 2.14%
15 ACLARIS THERAPEUTICS INC COM 647,944 17,456,000 2.09%
16 CHINA BIOLOGIC PRODS INC 111,500 15,884,000 1.90%
17 MIRATI THERAPEUTICS INC COM 495,356 15,653,000 1.87%
18 MACROGENICS INC 500,000 15,485,000 1.85%
19 TESARO INC 291,250 15,238,000 1.82%
20 CELLECTIS S A 469,145 14,558,000 1.74%
21 DYNAVAX TECHNOLOGIES CORP 575,000 13,892,000 1.66%
22 NOVAVAX INC COM 1,600,000 13,424,000 1.61%
23 COHERUS BIOSCIENCES INC COM 569,130 13,067,000 1.56%
24 NEKTAR THERAPEUTICS COM 765,156 12,893,000 1.54%
25 DEXCOM 153,000 12,531,000 1.50%
26 COLLEGIUM PHARMACEUTICAL INC COM 450,000 12,375,000 1.48%
27 ULTRAGENYX PHARMACEUTICAL INC COM 109,500 12,284,000 1.47%
28 ROCKWELL MED INC COM 1,105,000 11,315,000 1.35%
29 VITAE PHARMACEUTICALS INC 623,409 11,284,000 1.35%
30 BIOCRYST PHARMACEUTICALS 1,080,000 11,146,000 1.33%
31 MYOKARDIA INC 753,388 11,045,000 1.32%
32 ACCELERON PHARMA 200,000 9,752,000 1.17%
33 SERES THERAPEUTICS INC 250,000 8,773,000 1.05%
34 LIPOCINE INC NEW 666,666 8,620,000 1.03%
35 ADVAXIS INC COM NEW 800,000 8,048,000 0.96%
36 CYTOMX THERAPEUTICS INC COM 371,023 7,743,000 0.93%
37 PFENEX INC COM 624,900 7,736,000 0.93%
38 AGENUS INC 1,559,000 7,078,000 0.85%
39 SOCIETAL CDMO INC 780,000 7,020,000 0.84%
40 MINERVA NEUROSCIENCES INC COM 1,145,043 6,950,000 0.83%
41 FORWARD PHARMA A/S 335,068 6,366,000 0.76%
42 WAVE LIFE SCIENCES LTD 392,079 6,254,000 0.75%
43 BELLICUM PHARMACEUTICALS INC COM 300,000 6,081,000 0.73%
44 DERMIRA INC 170,000 5,884,000 0.70%
45 ACHILLION PHARMACEUTICALS INC COM 500,000 5,395,000 0.65%
46 Intec Pharma Ltd 800,000 4,288,000 0.51%
47 EPIZYME INC COM 266,250 4,265,000 0.51%
48 KITE PHARMA INCORPORATED 68,800 4,239,000 0.51%
49 CELYAD SA 75,000 4,094,000 0.49%
50 Atara Biotherapeutics Inc 150,000 3,962,000 0.47%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-053224, filed 2016.02.16).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.